# BridgeBio Pharma, Inc.: Form SCHEDULE 13D/A, filed Jul 10, 2026

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-10
- Accepted by EDGAR: Jul 10, 2026, 19:03 ET
- Period: not reported
- Accession: 0000905148-26-003237
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000090514826003237/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000090514826003237/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000090514826003237/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 10, 2026.
Source: SEC EDGAR, the filing index for accession 0000905148-26-003237. Last ingested by Listed: Oct 29, 2026, 19:20 ET. No prices; not investment advice.